Aemetis

Aemetis, Inc. is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. It operates through the North America and India geographical segments. The North America segment manages Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, California, the Goodland Plant, Kansas and the research and development facility in Minnesota. The India segment refers to the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2006 and is headquartered in Cupertino, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Aemetis reports Q4 losses, eyes revenue growth in sustainable fuels

Aemetis faces profitability challenges despite revenue growth, with a focus on achieving positive cash flow in 2023 from key operational segments.
Regulatory delays and operational hurdles in RNG production pose risks, while signed contracts for sustainable fuels present revenue growth potential.
The company's strategic vision for revenue targets and sustainability aligns with market trends, offering growth opportunities in diversified segments.

Aemetis reports Q1 revenue decline, focuses on sustainable growth

Aemetis faced revenue decline and losses in Q1 2023 but is strategically focused on sustainable projects and financial restructuring to avoid shareholder dilution.
The company's investments in carbon projects, biodiesel, and sustainable aviation fuel offer growth potential and opportunities for revenue generation.
Challenges include lower margins in biodiesel sales, inventory value fluctuations, and refinancing preferred stock, but Aemetis is actively addressing these issues.
Overall, Aemetis is navigating operational challenges while capitalizing on opportunities in sustainable energy projects and financial restructuring.

Aemetis reports Q2 revenue decline, eyes sustainable growth opportunities

Aemetis navigated challenges in Q2 2023 with a focus on growth and sustainability.
Strategic investments in biogas digesters and carbon capture projects position the company well.
Despite market uncertainties, Aemetis remains agile and aims for revenue expansion and operational improvements.

Aemetis reports mixed Q3 results, eyes growth in sustainable fuels

Aemetis navigated mixed financial results in Q3 2023, with revenue decline but improved profitability driven by strategic initiatives and tax credit sales.
The company's focus on sustainable fuel products and expansion in India present growth opportunities, although challenges like delayed approvals and cash flow management persist.
Overall, Aemetis is strategically positioned for growth, aiming for significant revenue targets and pursuing expansion plans with a focus on sustainability and financial prudence.

Aemetis reports Q4 revenue growth, plans India IPO for expansion

Aemetis' financial performance in Q4 2023 and full year 2023 showed mixed results with revenue growth but significant net losses. The company's focus on sustainable aviation fuel, renewable diesel, and carbon capture projects presents promising growth avenues. Challenges include cash constraints, operational disruptions, and financing delays impacting project timelines.

Aemetis reports Q1 revenue growth, eyes biogas and India expansion

Aemetis is navigating challenges with losses and working capital needs but is capitalizing on strengths in biogas, sustainable aviation fuel, and India Biofuels business.
The company's focus on revenue generation through LCFS credits, India IPO plans, and innovative pricing strategies positions it for future growth.
Effective financial management and strategic market positioning will be crucial for Aemetis to overcome challenges and leverage growth opportunities.

Aemetis reports revenue growth but increased losses, eyes sustainable fuel

Aemetis' Q2 2024 performance showed mixed results with revenue growth but increased losses and declining cash reserves.
The company's strategic focus on renewable energy sectors and regulatory developments offer potential for future growth and market expansion.
While facing challenges in financial performance, Aemetis is pursuing opportunities in sustainable fuel production and energy efficiency projects.
Investors should monitor Aemetis' progress in executing its 5-year plan and navigating market dynamics to assess long-term viability and growth potential.

Aemetis reports revenue growth but faces net loss challenges

Aemetis demonstrated revenue growth and positive EBITDA in its India Biodiesel business.
While facing challenges with net losses and low cash reserves, the company is pursuing expansion opportunities.
Analyst inquiries reflected interest in various aspects of Aemetis' operations and future prospects.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hybrid Electric Vehicles to be Supplied with Below Zero Carbon Intensity Biofuel

U.S. Patent Awarded and Exclusively Licensed to Aemetis Enabling Launch of “Carbon Zero” Production Plants

Aemetis (AMTX) stock is heading higher on Tuesday after announcing a deal with Nevo Motors that gives it a 20% stake in the company. The post AMTX Stock: 10 Things for Aemetis Investors to Know About the Nevo Motors Deal appeared first on InvestorPlace.

AMTX Stock: 10 Things for Aemetis Investors to Know About the Nevo Motors Deal

AMTX stock is trending higher thanks to an analyst upgrade and its clean energy focus. Here's what you need to know.

AMTX Stock: 11 Things for Potential Aemetis Investors to Know Today

CUPERTINO, CA, Nov. 23, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX) announced today that its wholly-owned subsidiary, Aemetis Health Products, Inc., received a $24 million initial purchase order after signing a supply agreement for sanitizer alcohol and nitrile gloves with a California distributor that provides health safety products to the state of California as well as other governmental entities and large hospital chains throughout the U.S. 

Aemetis Signs Distributor Agreement for Health Safety Products and Receives $24 Million Initial Purchase Order

CUPERTINO, CA, Nov. 20, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aemetis, Inc. (NASDAQ: AMTX) announced today that its wholly-owned subsidiary, Aemetis Biogas LLC, has been awarded $7.8 million in matching grants through the 2020 California Department of Food and Agriculture (CDFA) Dairy Digester Research and Development Program (DDRDP).  Aemetis Biogas was awarded approximately 50% of the total projects awarded in the 2020 DDRDP grant cycle.  The DDRDP provides financial assistance for the installation of dairy digesters in California, which will result in reduced greenhouse gas emissions through the production of renewable natural gas (RNG) for transportation fuel.  Aemetis was previously awarded $3.1 million through the 2018 DDRDP grant cycle, and successfully completed two digesters and four miles of private pipeline as phase one of its 18 dairy digester cluster.

Aemetis Biogas Awarded $7.8 Million in CDFA Grants for Phase 2 RNG Dairy Digester Project

McAfee

Aemetis, Inc. (AMTX) CEO Eric McAfee on Q3 2020 Results - Earnings Call Transcript

Shares of Aemetis (NASDAQ:AMTX) tumbled 35% after the company reported Q3 results. Quarterly Results Earnings per share were down 90.32% over the past year to ($0.59), which missed the estimate of ($0.05).

Recap: Aemetis Q3 Earnings

CUPERTINO, CA, Nov. 06, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its third quarter 2020 earnings report:

Aemetis to Review Third Quarter Financial Results on November 12, 2020

First Two Dairies and Private Pipeline Operating; Below Zero Carbon Intensity Gas Now Producing Transportation Fuel

Aemetis Begins Production of Below Zero Carbon Intensity Dairy Biogas

American Resources Corp

Blueknight Energy Partners, L.P.

Dynagas LNG Partners LP

Evolve Transition Infrastructure LP

Tengasco

According to the GuruFocus All-in-One Screener, a Premium feature, the stocks of the following guru-owned energy companies have outperformed the S&P 500 Index over the past 12 months through Oct. 19.

6 Energy Stocks Outperforming the Benchmark

NEW YORK, Oct. 5, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aemetis, Inc. (NASDAQ: AMTX). If you are a...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aemetis, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

Aemetis Health Products Brand to be Sold on Amazon and Through Retail Chains

Aemetis Starts Production of Branded High-Grade Alcohol Sanitizer Products

71 Investors Received Conditional Permanent Residency by Creating Jobs in Central California

Aemetis, Inc.Closes $35.5 Million Phase I EB-5 Program

Aemetis (NASDAQ: AMTX) shares are trading higher on Tuesday after the company announced it received an FDA national drug code for its OTC sanitizer products.

Why Aemetis' Stock Is Trading Higher Today

Hand Sanitizer and Other Sanitizer Products to be Produced for Consumer Markets and to Fight COVID-19 Pandemic

Aemetis Receives FDA National Drug Code for OTC Sanitizer Products

Project to Produce Below Zero Carbon Intensity RNG for Transportation Markets and High Grade Alcohol Production

Aemetis Completes Construction of Phase I Dairy Digester and Pipeline Project for Renewable Natural Gas Production

CUPERTINO, CA, Aug.  18, 2020  (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aemetis, Inc. (NASDAQ: AMTX) announced it received a letter from The NASDAQ Stock Market (“NASDAQ”) on August 11, 2020, which contained a NASDAQ compliance determination that the Company has regained compliance with NASDAQ Listing Rule 5450(b)(2)(C), which requires that listed securities maintain a minimum market value of publicly held shares of the Company’s common stock equal to or in excess of the $15,000,000 minimum.  On August 12, 2020, Aemetis received a letter from NASDAQ confirming compliance with NASDAQ Listing Rule 5450(a)(1), which requires that listed securities maintain a closing bid price equal to or in excess of $1.00 per share.

Aemetis Regains Compliance with NASDAQ Listing Requirements

Aemetis, Inc. (AMTX) CEO Eric McAfee on Q2 2020 Results - Earnings Call Transcript

Company to offer Blended Liquid and Gel Hand Sanitizer as Bulk and Packaged Products

Aemetis Launches Aemetis Health Products Subsidiary

CUPERTINO, CA, Aug.  10, 2020  (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its second quarter 2020 earnings report:

Aemetis to Review Second Quarter Financial Results on August 13, 2020

Aemetis, Inc. (AMTX) CEO Eric McAfee on Q1 2020 Results - Earnings Call Transcript

Ethanol Plant to Provide About 450 tons of CO2 Daily    for use in Food, Beverage and Other Industries; Helps Meet Market Shortage Caused by COVID-19 Crisis

Aemetis Begins Deliveries of Carbon Dioxide Under Supply Agreement With New Messer CO2 Plant

Advanced Biofuel Company Helping Meet Sanitizer Demand Due to COVID-19 Pandemic

Aemetis Begins Shipping High Purity Alcohol for Hand Sanitizer

Aemetis, Inc. (AMTX) CEO Eric McAfee on Q4 2019 Results - Earnings Call Transcript

Andersons

Green Plains

Alto Ingredients

REX American Resources

The Trump Administration Reverses Course And Sides With Refiners On Small Refinery Exemptions

News for Aemetis Stock (AMTX)